Parker Waichman Alonso LLP Supports FDA Advisory Panel Recommendation that Yaz and Yasmin Labels be

Parker Waichman Alonso LLP, a National Law Firm, Urges the FDA to Follow the Recommendation of its Outside Experts and Immediately Update the Labels of Yaz, Yasmin and Other Drospirenone Birth Control Pills with Stronger Warnings Regarding Their Association with a Higher Risk of Blood Clots New York, New York (PRWEB) December 09, 2011 Parker Waichman Alonso LLP urges the U.S. Food & Drug Administration (FDA) to accept the recommendation of its outside advisors to update the labels for Yaz, Yasmin and other birth control pills containing the synthetic progestin, drospirenone, with infor
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations